Clinical Trials on Triple Negative Breast Carcinoma
Total 2499 results
-
Tongji HospitalRecruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast CancerChina
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.RecruitingTNBC - Triple-Negative Breast CancerChina
-
Stephen ShiaoMerck Sharp & Dohme LLC; Incyte CorporationRecruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Zhenzhen LiuRecruitingBreast Cancer | Triple Negative Breast Cancer | CamrelizumabChina
-
Xijing HospitalRoche Pharma AGUnknownBreast Cancer | Triple Negative Breast Cancer | CapecitabineChina
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
Hubei Cancer HospitalNot yet recruiting
-
Regina Elena Cancer InstituteFondazione Policlinico Universitario Agostino Gemelli IRCCS; Catholic University... and other collaboratorsRecruiting
-
Ourotech, Inc.Barts & The London NHS Trust; Imperial College Healthcare NHS Trust; Hampshire... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast CancerUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast CancerUnited States
-
Vall d'Hebron Institute of OncologyRecruitingTriple Negative Breast CancerSpain
-
Fudan UniversityRecruitingBreast Cancer | Triple Negative Breast CancerChina
-
Power Life Sciences Inc.Not yet recruitingBreast Cancer | Triple Negative Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
M.D. Anderson Cancer CenterGilead SciencesRecruiting
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Ourotech, Inc.Barts & The London NHS TrustRecruitingTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsUnited Kingdom
-
Nova Scotia Health AuthorityObafemi Awolowo UniversityNot yet recruitingTriple Negative Breast Cancer
-
University of Alabama at BirminghamNot yet recruitingTriple Negative Breast CancerUnited States
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
University of Illinois at ChicagoRecruitingTriple Negative Breast CancerUnited States
-
Shengjing HospitalRecruiting
-
European Institute of OncologyRecruitingTriple Negative Breast CancerItaly
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Jeong Eon LeeAsan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital and other collaboratorsActive, not recruiting
-
Fudan UniversityActive, not recruitingTA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureBreast Cancer | Triple Negative Breast CancerChina
-
Tata Memorial HospitalActive, not recruiting
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more
-
Baylor Research InstituteEli Lilly and CompanyCompletedTriple Negative Breast CancerUnited States
-
Joyce O'ShaughnessyTakedaCompletedTriple Negative Breast CancerUnited States
-
Indiana UniversityCompletedTriple Negative Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaTrans Tasman Radiation Oncology GroupCompleted
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Brooklyn ImmunoTherapeutics, LLCActive, not recruitingBreast Cancer | Breast NeoplasmsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedBreast Cancer | Triple Negative Breast CancerChina
-
NYU Langone HealthNational Institutes of Health (NIH)TerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuspended
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
Hebei Medical University Fourth HospitalWithdrawnTriple Negative Breast CancerChina
-
Leo W. Jenkins Cancer CenterTerminatedBreast CancerUnited States
-
University of Wisconsin, MadisonActive, not recruitingBreast Cancer | Triple Negative Breast CancerUnited States